KROS Working Capital Ratio

Keros Therapeutics Inc · Working Capital Ratio

KROS logo

KROS Working Capital Ratio

Latest reported87.28%
KROS FY Working Capital Ratio (51.30% → 87.28%)
High-resolution chart · PNG

KROS working capital ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Working Capital Ratio — Annual fiscal periods
Period endingWorking Capital Ratio
87.2786%
91.1602%
87.2698%
87.7564%
93.866%
96.6965%
40.5386%
51.2987%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.